Therefore, this study aimed to investigate the effect of co-administration of L-arginine (L-arg) as a NO precursor and L-N(G)-Nitro arginine methyl ester (L-NAME) as a NOS inhibitor with GER. The gene discussed is NOS2; the disease is gastroesophageal reflux disease.